Translational research plays an important role in Intermountain Healthcare’s mission to help people live the healthiest lives possible. We strive to support researchers and investigators by combining our translational science expertise with an emphasis on projects in precision medicine.

Intermountain Precision Genomics will fund up to $200,000 total investment for proposals that are innovative, creative, and advance our mission of helping people live the healthiest lives possible.

We welcome biomedical research proposals with potential for direct clinical application.

The Genomic Innovation Grants program offers capabilities in the following:

  • Access to samples and associated clinical data
  • Sequencing services (whole genome, whole exome, RNA-seq, and single cell RNA-seq)
  • Bioinformatic analysis

The Intermountain Healthcare Biorepository is a major asset as a best-in-class biobank, housing more than 4.5 million archived patient tissue samples dating to 1971, each uniquely linked to decades of clinical outcomes data.

Our access to Biorepository samples and associated electronic medical records, coupled with our next-generation sequencing proficiency, can benefit your best ideas. We aim to help you link genomics to innovation.

Fall 2019 Genomic Innovation Grants

Intermountain Precision Genomics is calling for brief research proposals to be submitted by groups interested in these translational science services either in conjunction with Biorepository samples or as a standalone sequencing service for precision medicine applications.

Funding

Funds are designated to cover costs of procuring, preparing, sequencing, and analyzing samples at Intermountain and exclude indirect costs, investigator salaries, and expenses incurred in the acquisition and preparation of project samples. All awarded funding must be expended at Intermountain facilities by the end of the year 2020 and cannot be disbursed to third parties.

Application Process

Applications will be evaluated by a panel of scientists from different biomedical disciplines and should be written for this audience. Projects will be evaluated on the likelihood of providing scientific impact and influence on the research field involved using the National Institutes of Health (NIH) review criteria of assessing significance, innovation, and approach. It is anticipated that project awards will result in one or more collaborative peer-reviewed publications with Intermountain and provide pilot data for larger collaborative endeavors and/or extramural grant applications.

The following United States organizations are eligible to apply:

For-profit organizations including commercial, biotechnology and biopharma industries

  • Small businesses
  • Nonprofits
  • Institutions of Higher Education

Non-United States institutions or foreign components of U.S. organizations are NOT eligible to apply. Submitted proposals will be held confidential.

Fall Submission Deadline: November 15, 2019

Selected projects will be announced by January 20, 2020

Apply Now

Fill out this form to request a Genomic Innovation Grants application.

Please read the application instructions carefully and submit proposals via email to genomicsgrants@imail.org with attention to the Research Review Committee.

A non-disclosure agreement can be arranged if intellectual property will be included in the application.

If you have additional questions, please visit our FAQ page or contact us for more information.

A female physician consults with a female patient in a clinic exam room

Frequently Asked Questions

Frequently asked questions about funding, samples, and services provided through Genomic Innovation Grants for biomedical projects.
GeneTarget_DR

Application Request Form

Submit your biomedical research proposals to the Genomic Innovation Grants program.